Revascularbio
Suita, JP · 1 known investors
Revascular Bio develops cell therapy treatments using vascular endothelial stem cells to address diseases caused by vascular dysfunction, including chronic wounds, severe limb ischemia, and genetic blood disorders. The company targets intractable diseases with angiogenic therapy, angiocrine therapy, and protein production platforms.
Founders & leadership
SO
Shinsei OmoriRepresentative Director, President & CEO
Investors · 1
Frequently asked questions
- What does Revascularbio do?
- Revascular Bio develops cell therapy treatments using vascular endothelial stem cells to address diseases caused by vascular dysfunction, including chronic wounds, severe limb ischemia, and genetic blood disorders. The company targets intractable diseases with angiogenic therapy, angiocrine therapy, and protein production platforms.
- Who are Revascularbio's investors?
- Revascularbio's investors include OSAKA University Venture Capital.
- Where is Revascularbio headquartered?
- Revascularbio is headquartered in Suita, JP.